Global Oncology Academy

Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALL
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
- Charles Turck, PharmD, BCPS, BCCCP
- Lena Winestone, MD, MSHP
A New Era of Hope in Non-Small Cell Lung Cancer Care
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®
A New Era of Hope in Non-Small Cell Lung Cancer Care
- Geoffrey Oxnard, MD
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
- Charles Turck, PharmD, BCPS, BCCCP
- Kelly McCann, MD, PhD
- Gregory Vidal, MD, PhD
Cosibelimab Delivers Durable Responses in Advanced CSCC
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®
Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Expanding Molecular Testing in Community NSCLC Care
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®
Expanding Molecular Testing in Community NSCLC Care
- Apar Kishor Ganti, MD, MS
Oncogenic Drivers in Never-Smokers with NSCLC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Project Oncology®
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
- Brian P. McDonough, MD, FAAFP
- Christopher T. Chen, MD

Medical News

Medical News
Human hIEC Model Reports High Accuracy for Detecting Drug-Induced Intestinal Barrier Damage
03/10/2026
Read more
Medical News
Real‑World Data on Urothelial Carcinoma Treatment
03/09/2026
Read more
Medical News
Epredia–Mindpeak EU Distribution Deal Expands Technology Access
03/09/2026
Read more
Medical News
Genetic Atlas Identifies Switches Reversing CD8 T Cell Exhaustion
03/09/2026
Read more

See more news

CME/CE

Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
Addressing Unmet Needs in Metastatic Uveal Melanoma
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
1.00 credit
- Marlana Orloff, MD
- Gregory Daniels, MD, PhD
- Jesse Keller, MD
1.00 credit
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit

Clinical Practice

Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
- Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Integrating Molecular Testing into NSCLC Care
Project Oncology®
Integrating Molecular Testing into NSCLC Care
- Geoffrey Oxnard, MD
Smarter Screening for Non-Small Cell Lung Cancer
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®
Smarter Screening for Non-Small Cell Lung Cancer
- Jobelle Baldonado, MD
Recognizing High-Risk Profiles for NSCLC
Recognizing High-Risk Profiles for NSCLC
Project Oncology®
Recognizing High-Risk Profiles for NSCLC
- Jobelle Baldonado, MD

Programs

Addressing Unmet Needs in First-Line mTNBC Care
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
- Jennifer Caudle, DO, FACOFP
- Alexis Ann LeVee, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
Optimizing Care for Older Adults With FLT3-Mutated AML
Global Oncology Academy
Optimizing Care for Older Adults With FLT3-Mutated AML
- Ryan Quigley
- Nicholas Short, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
- Maxwell Llyod, MD
- Ryan Quigley
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer